Demographic, Social, and Clinical Profiles of Patients Initiating Lecanemab in Clinical Practice: A Single-Center Experience in Korea
Jeongha Lee, Hyeongjin Kim, Hee Kyung Park, Suah Kim, Kyung Bok Lee, Heekyoung Kang, Daeun Shin, Jun Pyo Kim, Byung Hwa Lee · 2026
Read Demographic, Social, and Clinical Profiles of Patients Initiating Lecanemab in Clinical Practice: A Single-Center Experience in Korea by Jeongha Lee, Hyeongjin Kim, Hee Kyung Park, Suah Kim, Kyung Bok Lee, Heekyoung Kang, Daeun Shin, Jun Pyo Kim, Byung Hwa Lee (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13136623.txt.
Description
b demonstrated modest but statistically significant slowing of cognitive decline in patients with early AD and has since entered routine clinical use in several countries, including Korea.34 However, its implementation requires biweekly infusions and repeated clinical monitoring, including magnetic resonance imaging, resulting in substantial financial burden.4 These requirements may influence access to treatment.
Catalog record
| CREATOR | Jeongha Lee, Hyeongjin Kim, Hee Kyung Park, Suah Kim, Kyung Bok Lee, Heekyoung Kang, Daeun Shin, Jun Pyo Kim, Byung Hwa Lee |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 6 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |